Allavena, Paola
Humanitas Research Hospital,
Italy
2025 Rank: 27,314
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 544 out of 166,615 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27,314 | 31,450 |
| Total Cites | 3,750 | 3,801 |
| H-index | 22 | 22 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 50 | 50 |
| Total Cites to Single+First Authored Papers | 199 | 202 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 1,149 | 1,164 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,091 | 3,120 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.22 |
| Self-Citation Percentage |
1.34%
|
|
Allavena, Paola
Humanitas Research Hospital,
Italy
2024 Rank: 21,841
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 454 out of 157,372 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 21,841 | 24,064 |
| Total Cites | 3,788 | 3,868 |
| H-index | 23 | 23 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 194 | 197 |
| Number of Single+First+Last Authored Papers | 114 | 114 |
| Total Cites to Single+First+Last Authored Papers | 1,239 | 1,270 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,077 | 3,113 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.24 |
| Self-Citation Percentage |
2.07%
|
|
Allavena, Paola
Humanitas Research Hospital,
Italy
2023 Rank: 18,904
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 447 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,904 | 21,848 |
| Total Cites | 4,002 | 4,069 |
| H-index | 25 | 25 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 49 | 49 |
| Total Cites to Single+First Authored Papers | 240 | 247 |
| Number of Single+First+Last Authored Papers | 112 | 112 |
| Total Cites to Single+First+Last Authored Papers | 1,386 | 1,414 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,176 | 3,206 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
1.65%
|
|
Allavena, Paola
Humanitas Research Hospital,
Italy
2022 Rank: 18,742
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 516 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 18,742 | 22,036 |
| Total Cites | 3,994 | 4,098 |
| H-index | 25 | 25 |
| Hm-index | 9 | 9 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 202 | 209 |
| Number of Single+First+Last Authored Papers | 108 | 108 |
| Total Cites to Single+First+Last Authored Papers | 1,365 | 1,414 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,187 | 3,221 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.27 |
| Self-Citation Percentage |
2.54%
|
|
Allavena, Paola
Humanitas Research Hospital,
Italy
2021 Rank: 24,172
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 610 out of 127,911 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24,172 | 28,234 |
| Total Cites | 5,764 | 5,887 |
| H-index | 29 | 29 |
| Hm-index | 10 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 288 | 291 |
| Number of Single+First+Last Authored Papers | 105 | 105 |
| Total Cites to Single+First+Last Authored Papers | 1,880 | 1,926 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,556 | 4,603 |
| Ratio of Total Citations to Distinct Citing Papers | 1.27 | 1.28 |
| Self-Citation Percentage |
2.09%
|
|
Allavena, Paola
IRCCS Foundation Rome,
Italy
2020 Rank: 22,381
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 516 out of 108,509 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22,381 | 25,370 |
| Total Cites | 4,156 | 4,251 |
| H-index | 24 | 25 |
| Hm-index | 9 | 10 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 45 | 45 |
| Total Cites to Single+First Authored Papers | 241 | 244 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 1,292 | 1,329 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,292 | 3,337 |
| Ratio of Total Citations to Distinct Citing Papers | 1.26 | 1.27 |
| Self-Citation Percentage |
2.23%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.